The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy
James R. Woodburn · Pharmacology & Therapeutics · 1999
Cited by 827 works. doi:10.1016/s0163-7258(98)00045-x
Authors
References
- Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
- Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
- Epidermal growth factor-related peptides and their receptors in human malignancies
- Transforming Growth Factor-α: a More Potent Angiogenic Mediator than Epidermal Growth Factor
- Tyrosine Kinase Inhibition: An Approach to Drug Development
- Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt
- Changing views of the role of matrix metalloproteinases in metastasis
- BindingDB Entry 50022536: Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
- Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.
- Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival